Advertisement

Studies of TGEV Spike Protein Gp195 Expressed in E. Coli and by a TGE-Vaccinia Virus Recombinant

  • Sylvia Hu
  • Joan Bruszewski
  • Ralph Smalling
  • Jeffrey K. Browne
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 185)

Abstract

The gene coding for the surface spike protein gp195 of TGEV has been cloned and expressed in E. coli in the form of fusion proteins. These proteins were isolated and used to immunize laboratory animals. All animals developed antibodies cross-reacting with the TGEV virion but failed to neutralize the virus. The entire gp195 gene was also inserted into vaccinia to generate a TGEV-vaccinia recombinant virus (vTGE) that expressed TGEV gp195. Animals vaccinated with vTGE produced neutralizing antibodies against both TGEV and vaccinia. These results suggest the potential use of the recombinant vTGE as a vaccine against TGEV infection.

Keywords

Vaccinia Virus Protein GP195 Immunoperoxidase Staining Vaccinia Virus Recombinant Mouse Hepatitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bohl, E.H., Gupta, P.K.P., Olquin, M.V.F., and Saif, L., 1972. Antibody responses in serum, colostrum and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect. Immun. 6: 289–301.PubMedGoogle Scholar
  2. Bohl, E.H., and Saif, L.J., 1975. Passive immunity in transmissible gastroenteritis of swine: Immunoglobulin characteristics of antibodies in milk after inoculating virus by different routes. Infect. Immun. 11: 23–32.PubMedGoogle Scholar
  3. Bohl, E.H., 1981. Transmissible gastroenteritis, in: “Disease of Swine”, A.D. Leman et al. (eds.), Iowa State Press, Ames, Iowa. pp. 195–208.Google Scholar
  4. Collins, A.R., Knobler, R.L., Powell, H., and Buchmeier, M.J., 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119: 358–371.PubMedCrossRefGoogle Scholar
  5. Holmes, K.V., Doller, E.W., and Sturman, L.S., 1981. Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein. Virology 115: 334–344.Google Scholar
  6. Hu, S., Bruszewski, J., Boone, T., and Souza, L., 1984. Cloning and expression of the surface glycoprotein gp195 of porcine transmissible gastroenteritisGoogle Scholar
  7. virus. In: “Modern Approaches to Vaccines”, R.M. Chanock and R.A. Lerner (eds.). Cold Spring Harbor Laboratory, New York., pp. 219–223.Google Scholar
  8. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.PubMedCrossRefGoogle Scholar
  9. Mackett, M., Smith, G.L., and Moss, B., 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49: 857–864.PubMedGoogle Scholar
  10. McClurkin, A.W.., 1965. Studies on transmissible gastroenteritis of swine I. The isolation and identification of a cytopathogenic virus of transmissible gastroenteritis in primary swine kidney cell cultures. Can. J. Comp. Med. 29: 46–53.PubMedGoogle Scholar
  11. Niemann, H., and Klenk, H.-D., 1981. Coronavirus glycoprotein El, a new type of viral glycoprotein. J. Mol. Biol. 153: 993–1010.Google Scholar
  12. Oppermann, H., Levinson, A.D., Varmus, H.E., Levintow, L., and Bishop, J.M., 1979. Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc. Natl. Acad. Sci. (U.S.A.). 76: 1804–1808.CrossRefGoogle Scholar
  13. Paoletti, E., Lipinskas, B.R., Samsonoff, C., Mercer, S., and Panicali, D., 1984. Construction of live vaccines using genetically engineered poxviruses: Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc. Natl. Acad. Sci. (U.S.A.) 81: 193–197.CrossRefGoogle Scholar
  14. Rottier, P.J.M., Horzinek, M.C., and van der Zeijst, B.A.M., 1981. Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: Effect of tunicamycin. J. Virol. 40: 350–357.PubMedGoogle Scholar
  15. Smith, G.L., Murphy, B.R., and Moss, B., 1983. Construction and characterization of an influenza vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc. Natl. Acad. (U.S.A.). 80: 7155–7159.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Sylvia Hu
    • 1
  • Joan Bruszewski
    • 1
  • Ralph Smalling
    • 1
  • Jeffrey K. Browne
    • 1
  1. 1.AmgenThousand OaksUSA

Personalised recommendations